Article,

Study of polymorphism in imatinib mesylate: A quantum chemical approach using electronic and vibrational spectra

, , , , , and .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, (2013)
DOI: 10.1016/j.saa.2012.10.066

Abstract

Imatinib mesylate, 4-( 4-methyl-piperazin-1-ylmethyl)-N-u4-methyl-3-(4-pyridin-3-yl)pyrimidi ne-2-ylamino)phenyl benzamide methanesulfonate is a therapeutic drug that is approved for the treatment of chronic myelogeneous leukemia (CML) and gastrointestinal stromal tumors (GIST). It is known that imatinib mesylate exists in two polymorphic forms alpha and beta. However, beta-form is more stable than the alpha-form. In this work, we present a detailed vibrational spectroscopic investigation of beta-form by using FT-IR and FT-Raman spectra. These data are supported by quantum mechanical calculations using DFT employing 6-311G(d,p) basis set, which allow us to characterize completely the vibrational spectra of this compound. The FT-IR spectrum of alpha-form has also been discussed. The importance of hydrogen-bond formation in the molecular packing arrangements of both forms has been examined with the vibrational shifts observed due to polymorphic changes. The red shift of the NH stretching bands in the infrared spectrum from the computed wavenumber indicates the weakening of the NH bond. The UV-vis spectroscopic studies along with the HOMO-LUMO analysis of both polymorphs (alpha and beta) were performed and their chemical activity has been discussed. The TD-DFT method was used to calculate the electronic absorption spectra in the gas phase as well as in the solvent environment using IEF-PCM model and 6-31G basis set. Finally, the results obtained complements to the experimental findings. (C) 2012 Elsevier B.V. All rights reserved.

Tags

Users

  • @ppgfis_ufc_br

Comments and Reviews